Atea Pharmaceuticals Provides Update and Topline Results for Phase 2 MOONSONG Trial Evaluating AT-527 in the Outpatient Setting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. AAPL
3. TTAN
4. CHYM
5. USO
6. COO
7. QCOM
8. IRT
9. AEO
10. MSI

Go back to Atea Pharmaceuticals Provides Update and Topline Results for Phase 2 MOONSONG Trial Evaluating AT-527 in the Outpatient Setting
(NASDAQ: AVIR) Delayed: 5.27 -0.41 (7.22%)
Previous Close $5.68    52 Week High $2.00 
Open $5.64    52 Week Low $1.15 
Day High $5.66    P/E N/A 
Day Low $5.24    EPS $0.00 
Volume 430,821